SGPSpyGlass Pharma, Inc.vs its industry peers
A metric-by-metric comparison of SpyGlass Pharma, Inc. against SIC 3841 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Empresa | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SGPEsta | $966M#8 | — | 4.2x#8 | — | — | -36.7%#12 | — | -17.2%#7 | — | — | — | — |
| ATEC | $1.6B#1 | — | — | 2.2x#5 | 25.0%#5 | 11.6%#6 | -10.7%#4 | — | -18.5%#6 | 6#2 | — | — |
| KMTS | $1.5B#2 | — | 6.8x#10 | 15.8x#13 | 59.0%#2 | -15.6%#10 | -141.6%#13 | -59.2%#12 | -59.5%#10 | 4#6 | 11.3%#3 | — |
| AORT | $1.2B#3 | — | 2.8x#3 | 2.8x#7 | 13.6%#10 | 173.1%#1 | 7.6%#3 | 2.2%#3 | 3.0%#2 | 5#5 | -36.0%#6 | 0.3%#2 |
| IART | $1.2B#4 | — | 1.2x#1 | 0.7x#1 | 1.5%#13 | -7389.9%#14 | -30.2%#10 | -49.5%#11 | -32.1%#9 | 6#2 | 3.9%#4 | — |
| TNDM | $1.1B#5 | — | 8.7x#11 | 1.1x#2 | 7.9%#12 | -113.2%#13 | -18.5%#8 | -157.0%#13 | -26.3%#8 | 3#8 | — | — |
| PRCT | $1.1B#6 | — | 3.2x#5 | 3.6x#8 | 37.2%#4 | -4.5%#7 | -33.7%#11 | -0.0%#4 | -63.4%#11 | 2#10 | -49.3%#7 | — |
| IRMD | $1.1B#7 | 46.0x#1 | 10.3x#12 | 12.6x#11 | 14.4%#9 | 16.9%#4 | 31.2%#1 | 22.1%#2 | — | — | 17.2%#2 | 1.4%#1 |
| BBNX | $865M#9 | — | 3.4x#6 | 8.6x#10 | 53.9%#3 | -33.7%#11 | -71.5%#12 | -28.6%#10 | — | — | -24.0%#5 | — |
| SIBN | $831M#10 | — | 4.6x#9 | 4.1x#9 | 20.2%#6 | 38.8%#2 | -11.1%#5 | -10.4%#5 | -12.0%#4 | 6#2 | 22.4%#1 | — |
| MDXG | $689M#11 | 118.3x#2 | 3.2x#4 | 1.6x#3 | 20.0%#7 | 14.5%#5 | 15.3%#2 | 22.5%#1 | 48.1%#1 | 8#1 | — | — |
| SSII | $661M#12 | — | 12.4x#13 | 15.6x#12 | 105.7%#1 | 36.7%#3 | -19.3%#9 | -22.7%#9 | -20.1%#7 | — | — | — |
| ANGO | $647M#13 | — | 3.8x#7 | 2.0x#4 | 9.5%#11 | -8.1%#9 | -12.5%#6 | -21.5%#8 | -16.5%#5 | 4#6 | — | — |
| KIDS | $606M#14 | — | 1.8x#2 | 2.6x#6 | 15.4%#8 | -4.8%#8 | -16.6%#7 | -11.5%#6 | -8.6%#3 | 3#8 | — | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 3841). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-09-15.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice